Salvia sclarea wound dressing and preparation method thereof

A technology of wound dressing and sclareol, which is applied in the field of Sclareus wound dressing and its preparation, can solve the problems of long treatment cycle, easy to leave scars, and unsatisfactory treatment effect, and achieve low cost, safe and convenient use , The effect of simple preparation process

Inactive Publication Date: 2016-07-13
SHANDONG RUIYING PIONEER PHARMA
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The effect of the existing drug therapy to promote wound healing is still not very satisfactory, the treatment cycle is long, and it is easy to leave scars

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Salvia sclarea wound dressing and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] A clarelia wound dressing, which contains 0.4 g of sclareol, 4 g of pearl powder, 5 g of notoginseng powder per 100 g of the dressing, 5 g of calcium-rich sodium alginate as a thickener, and purified water as the balance.

[0029] The preparation steps are:

[0030] (1) Add 4g of pearl powder, 5g of Panax notoginseng powder, and 0.4g of sclareol into 80g of purified water in turn, heat to 50°C, stir well and mix evenly.

[0031] (2) Add 5g of high-calcium sodium alginate to the drug obtained in step (1), add purified water to make up to 100g, heat to 75°C, heat for 30 minutes, stir evenly, cool, filter, and remove air bubbles to obtain aroma Perilla dressing.

[0032] (3) Fill the dressing obtained in step 2 directly, or make the dressing into a band-aid or plaster.

Embodiment 2

[0034] A clareth wound dressing, which contains 0.7 g of sclareol, 5 g of pearl powder, and 5 g of notoginseng powder per 100 g of the dressing, 5 g of high-calcium potassium alginate as a thickener, and the balance of purified water.

[0035] The preparation steps are:

[0036] (1) Add 5g of pearl powder, 5g of Panax notoginseng powder, and 0.7g of sclareol into 80g of purified water in turn, heat to 70°C, stir well and mix evenly.

[0037] (2) Add 5g of potassium alginate to the drug obtained in step (1), add purified water to make up to 100g, heat to 85°C, heat for 10 minutes, stir evenly, cool, filter, and remove air bubbles to obtain Sclaria dressing .

[0038] (3) Fill the dressing obtained in step 2 directly, or make the dressing into a band-aid or plaster.

Embodiment 3

[0040] A scarare wound dressing, which contains 0.5 g of sclareol, 3 g of pearl powder, 5 g of notoginseng powder per 100 g of the dressing, and 2 g of calcium-rich sodium alginate as a thickener.

[0041] The preparation steps are:

[0042] (1) Add 3g of pearl powder, 5g of Panax notoginseng powder, and 0.5g of sclareol into 80g of purified water in turn, heat to 60°C, stir well and mix well.

[0043] (2) Add 2g of high-calcium sodium alginate to the drug obtained in step (1), add purified water to make up to 100g, heat to 80°C, heat for 15 minutes, stir evenly, cool, filter, and remove air bubbles to obtain aroma Perilla dressing.

[0044] (3) Fill the dressing obtained in step 2 directly, or make the dressing into a band-aid or plaster.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a salvia sclarea wound dressing and a preparation method thereof, and belongs to the field of medicines for treating trauma infection. The salvia sclarea wound dressing contains active ingredients of sclareol, pearl powder and notoginseng powder. The sclareol achieves antibacterial and bactericidal effects, the notoginseng powder achieves the effects of dissipating blood stasis to stop bleeding, and removing swelling and easing pain, the pearl powder can remove toxicity and promote tissue regeneration, and the sclareol, the pearl powder and the notoginseng powder are compatible with one another to prevent infection, remove swelling and ease pain, enable skin to regenerate, and promote rapid healing of wounds, so that the salvia sclarea wound dressing has a significant curative effect on trauma wound healing, is quick to cure and does not leave any scar. By using the salvia sclarea wound dressing disclosed by the invention, a wound can be healed quickly in 1-2 days generally without any scar. The salvia sclarea wound dressing disclosed by the invention is a full traditional Chinese medicine formula, and is safe and convenient to use. The salvia sclarea wound dressing provided by the invention is simple in preparation process and low in cost.

Description

technical field [0001] The invention relates to the field of drugs for treating trauma infection, in particular to a clary perilla wound dressing and a preparation method thereof. Background technique [0002] Clary sage (Clary sage), native to the Grasse region of France, is currently the most important planting place for Clary basil in China. The main chemical components are terpenoids, phenolic aromatic acids, flavonoids and so on. [0003] The products that have been developed and marketed recently include: Sclareus Oil, Sclareus Extract, Sclareol, Sclareolactone and Ambrox, etc., which are widely used in daily chemicals and food flavors. For example, it is used for tobacco flavoring in patent No. CN201310568188, for cosmetic fragrances in patent No. CN201310282358, and for food flavoring in patent No. CN201210069849. [0004] In addition, Sclareus also has significant medicinal effects. In 1985, UlubelenA et al. isolated compounds such as ursolic acid and sclareol fro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L26/00A61L15/44A61L15/28A61K36/258A61P7/04A61P17/02A61K35/618A61K31/047
CPCA61L26/0066A61K31/047A61K35/618A61K36/258A61L15/28A61L15/44A61L26/0023A61L2300/30A61L2300/404A61L2300/412A61L2300/45A61L2400/04
Inventor 彭继先
Owner SHANDONG RUIYING PIONEER PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products